BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16286076)

  • 1. Local environmental effects on the structure of the prion protein.
    DeMarco ML; Daggett V
    C R Biol; 2005; 328(10-11):847-62. PubMed ID: 16286076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism for low pH triggered misfolding of the human prion protein.
    DeMarco ML; Daggett V
    Biochemistry; 2007 Mar; 46(11):3045-54. PubMed ID: 17315950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.
    Hornemann S; Glockshuber R
    J Mol Biol; 1996 Sep; 261(5):614-9. PubMed ID: 8800210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
    Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
    J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization.
    Kazlauskaite J; Sanghera N; Sylvester I; Vénien-Bryan C; Pinheiro TJ
    Biochemistry; 2003 Mar; 42(11):3295-304. PubMed ID: 12641461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photo-induced crosslinking of prion protein oligomers and prions.
    Piening N; Weber P; Högen T; Beekes M; Kretzschmar H; Giese A
    Amyloid; 2006 Jun; 13(2):67-77. PubMed ID: 16911960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the proapoptotic intracellular mechanisms induced by a toxic conformer of the recombinant human prion protein fragment 90-231.
    Villa V; Corsaro A; Thellung S; Paludi D; Chiovitti K; Venezia V; Nizzari M; Russo C; Schettini G; Aceto A; Florio T
    Ann N Y Acad Sci; 2006 Dec; 1090():276-91. PubMed ID: 17384271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metal ions on de novo aggregation of full-length prion protein.
    Giese A; Levin J; Bertsch U; Kretzschmar H
    Biochem Biophys Res Commun; 2004 Aug; 320(4):1240-6. PubMed ID: 15249223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for His155 in binding of human prion peptide144-167 to immobilised prion protein.
    Hesp JR; Raven ND; Sutton JM
    Biochem Biophys Res Commun; 2007 Oct; 362(3):695-9. PubMed ID: 17761148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the osmolyte trimethylamine N-oxide on the stability of the prion protein at low pH.
    Granata V; Palladino P; Tizzano B; Negro A; Berisio R; Zagari A
    Biopolymers; 2006 Jun; 82(3):234-40. PubMed ID: 16489585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
    El Moustaine D; Perrier V; Smeller L; Lange R; Torrent J
    FEBS J; 2008 May; 275(9):2021-31. PubMed ID: 18355314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics as an approach to study prion protein misfolding and the effect of pathogenic mutations.
    van der Kamp MW; Daggett V
    Top Curr Chem; 2011; 305():169-97. PubMed ID: 21526434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of a spontaneously aggregating amyloid-forming variant of human PrP((90-231)) through phage-display screening of variants randomized between residues 101 and 112.
    Verma A; Sharma S; Ganguly NK; Majumdar S; Guptasarma P; Luthra-Guptasarma M
    Int J Biochem Cell Biol; 2008; 40(4):663-76. PubMed ID: 18023239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamic and voltammetric characterization of the metal binding to the prion protein: insights into pH dependence and redox chemistry.
    Davies P; Marken F; Salter S; Brown DR
    Biochemistry; 2009 Mar; 48(12):2610-9. PubMed ID: 19196019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The determinants of stability in the human prion protein: insights into folding and misfolding from the analysis of the change in the stabilization energy distribution in different conditions.
    Colacino S; Tiana G; Broglia RA; Colombo G
    Proteins; 2006 Mar; 62(3):698-707. PubMed ID: 16432880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of the nucleated polymerization model of prion replication.
    Rubenstein R; Gray PC; Cleland TJ; Piltch MS; Hlavacek WS; Roberts RM; Ambrosiano J; Kim JI
    Biophys Chem; 2007 Feb; 125(2-3):360-7. PubMed ID: 17084016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational changes and development of proteinase K resistance in surface-immobilized PrP.
    Leclerc E; Vetter S
    Arch Virol; 2008; 153(4):683-91. PubMed ID: 18278426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.